Clinical Trial

Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients

Study acronym: MODUS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The hypothesis of the present study is that restoring nasal stimulation alleviates dyspnea and improves respiratory drive. The aim of this study is to compare three non-pharmacological approaches designed to restore nasal stimulation (continuous nasal airflow, nasal sprays, and facial airflow) in tracheotomized patients dependent on mechanical ventilation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-15; most recent amendment 2026-01-27.
Trial Details
NCT Number NCT07308171
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Ventilated Patients
Enrollment 24 participants
Start Date 2026-02
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-01-29